Cardiovascular risk scoring and magnetic resonance imaging detected subclinical cerebrovascular disease

Abstract Aims  Cardiovascular risk factors are used for risk stratification in primary prevention. We sought to determine if simple cardiac risk scores are associated with magnetic resonance imaging (MRI)-detected subclinical cerebrovascular disease including carotid wall volume (CWV), carotid intraplaque haemorrhage (IPH), and silent brain infarction (SBI). Methods and results A total of 7594 adults with no history of cardiovascular disease (CVD) underwent risk factor assessment and a non-contrast enhanced MRI of the carotid arteries and brain using a standardized protocol in a population-based cohort recruited between 2014 and 2018. The non-lab-based INTERHEART risk score (IHRS) was calculated in all participants; the Framingham Risk Score was calculated in a subset who provided blood samples (n = 3889). The association between these risk scores and MRI measures of CWV, carotid IPH, and SBI was determined. The mean age of the cohort was 58 (8.9) years, 55% were women. Each 5-point increase (∼1 SD) in the IHRS was associated with a 9 mm3 increase in CWV, adjusted for sex (P < 0.0001), a 23% increase in IPH [95% confidence interval (CI) 9–38%], and a 32% (95% CI 20–45%) increase in SBI. These associations were consistent for lacunar and non-lacunar brain infarction. The Framingham Risk Score was also significantly associated with CWV, IPH, and SBI. CWV was additive and independent to the risk scores in its association with IPH and SBI. Conclusion  Simple cardiovascular risk scores are significantly associated with the presence of MRI-detected subclinical cerebrovascular disease, including CWV, IPH, and SBI in an adult population without known clinical CVD.

[1]  Chiadi E. Ndumele,et al.  Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology. , 2019, Journal of the American College of Cardiology.

[2]  S. Larsson,et al.  Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain Injury: A Systematic Review and Meta-analysis , 2019, JAMA neurology.

[3]  J. Tu,et al.  Canadian Alliance for Healthy Hearts and Minds: First Nations Cohort Study Rationale and Design , 2018, Progress in community health partnerships : research, education, and action.

[4]  Xihai Zhao,et al.  Association of Progression of Carotid Artery Wall Volume and Recurrent Transient Ischemic Attack or Stroke: A Magnetic Resonance Imaging Study , 2018, Stroke.

[5]  S. Yusuf,et al.  Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world , 2017, Heart.

[6]  S. Yusuf,et al.  Reducing the Global Burden of Cardiovascular Disease, Part 1: The Epidemiology and Risk Factors. , 2017, Circulation research.

[7]  Benjamin F. J. Verhaaren,et al.  Carotid Plaque Morphology and Ischemic Vascular Brain Disease on MRI , 2017, American Journal of Neuroradiology.

[8]  Xihai Zhao,et al.  Association Between Carotid Atherosclerotic Plaque Calcification and Intraplaque Hemorrhage: A Magnetic Resonance Imaging Study , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[9]  N. Altaf,et al.  Magnetic Resonance Imaging Plaque Hemorrhage for Risk Stratification in Carotid Artery Disease With Moderate Risk Under Current Medical Therapy , 2017, Stroke.

[10]  Eric E. Smith,et al.  Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2017, Stroke.

[11]  Yefeng Cai,et al.  Risk factors between intracranial–extracranial atherosclerosis and anterior–posterior circulation stroke in ischaemic stroke , 2017, Neurological research.

[12]  M. Szklo,et al.  Carotid Intima‐Media Thickness Score, Positive Coronary Artery Calcium Score, and Incident Coronary Heart Disease: The Multi‐Ethnic Study of Atherosclerosis , 2017, Journal of the American Heart Association.

[13]  O. Franco,et al.  Determinants of carotid atherosclerotic plaque burden in a stroke-free population. , 2016, Atherosclerosis.

[14]  S. Yusuf,et al.  Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study , 2016, The Lancet.

[15]  Eric E. Smith,et al.  Rationale, design, and methods for Canadian alliance for healthy hearts and minds cohort study (CAHHM) – a Pan Canadian cohort study , 2016, BMC Public Health.

[16]  S. Yusuf,et al.  Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease. , 2016, The New England journal of medicine.

[17]  D. Bluemke,et al.  Advanced MRI for carotid plaque imaging , 2015, The International Journal of Cardiovascular Imaging.

[18]  Martin McKee,et al.  Cardiovascular risk and events in 17 low-, middle-, and high-income countries. , 2014, The New England journal of medicine.

[19]  John F Fraser,et al.  The epidemiology of silent brain infarction: a systematic review of population-based cohorts , 2014, BMC Medicine.

[20]  Arlen C. Moller,et al.  Healthy Lifestyle Change and Subclinical Atherosclerosis in Young Adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study , 2014, Circulation.

[21]  S. Connolly,et al.  Embolic strokes of undetermined source: the case for a new clinical construct , 2014, The Lancet Neurology.

[22]  David A Bluemke,et al.  Carotid artery plaque morphology and composition in relation to incident cardiovascular events: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2014, Radiology.

[23]  Pina C. Sanelli,et al.  Carotid Plaque MRI and Stroke Risk: A Systematic Review and Meta-analysis , 2013, Stroke.

[24]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[25]  Aad van der Lugt,et al.  Determinants of magnetic resonance imaging detected carotid plaque components: the Rotterdam Study. , 2012, European heart journal.

[26]  S. Yusuf,et al.  Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score. , 2011, European heart journal.

[27]  Salim Yusuf,et al.  Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries. , 2010, Journal of the American College of Cardiology.

[28]  E. Boerwinkle,et al.  Correlates of Carotid Plaque Presence and Composition as Measured by MRI: The Atherosclerosis Risk in Communities Study , 2009, Circulation. Cardiovascular imaging.

[29]  R. D'Agostino,et al.  Prevalence and Correlates of Silent Cerebral Infarcts in the Framingham Offspring Study , 2008, Stroke.

[30]  R. Kronmal,et al.  Risk Factor Associations With the Presence of a Lipid Core in Carotid Plaque of Asymptomatic Individuals Using High-Resolution MRI: The Multi-Ethnic Study of Atherosclerosis (MESA) , 2008, Stroke.

[31]  S. Yusuf,et al.  Social disadvantage and cardiovascular disease: development of an index and analysis of age, sex, and ethnicity effects. , 2006, International journal of epidemiology.

[32]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[33]  Ralph B D'Agostino,et al.  Framingham risk score and prediction of lifetime risk for coronary heart disease. , 2004, The American journal of cardiology.

[34]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[35]  Matthijs Oudkerk,et al.  Incidence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study , 2003, Stroke.

[36]  P. Toutouzas,et al.  A Magnetic Resonance Imaging Study , 2003 .

[37]  S. Yusuf,et al.  Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) , 2000, The Lancet.

[38]  H. Hendrickson.  Prevention of what? , 1983, Journal of the American Optometric Association.